Eisai
4523.T
#2511
Rank
NZ$12.88 B
Marketcap
NZ$45.66
Share price
1.92%
Change (1 day)
-2.10%
Change (1 year)
Eisai is a Japanese pharmaceutical company that is engaged in the R&D of drugs for the treatment of dementia and Alzheimer.

EPS for Eisai (4523.T)

EPS in 2025 (TTM): NZ$1.42

According to Eisai's latest financial reports the company's current EPS (TTM) is NZ$1.52. an increase over its 2024 EPS that were of NZ$1.72.

EPS history for Eisai from 2000 to 2025

Annual EPS

Year EPS Change
2025NZ$1.9211.85%
2024NZ$1.72-32.63%
2023NZ$2.555.52%
2022NZ$2.42-74.01%
2021NZ$9.29-66.58%
2020NZ$27.8098.24%
2019NZ$14.0217.01%
2018NZ$11.9837.78%
2017NZ$8.70-27.62%
2016NZ$12.0235.33%
2015NZ$8.88-2.82%
2014NZ$9.14-27.66%
2013NZ$12.63-27.49%
2012NZ$17.42-12.67%
2011NZ$19.9588.08%
2010NZ$10.61-11.06%
2009NZ$11.93-390.15%
2008NZ-$4.11-127.78%
2007NZ$14.8011.78%
2006NZ$13.244.38%
2005NZ$12.697.4%
2004NZ$11.8143.03%
2003NZ$8.2625.09%
2002NZ$6.6052.67%
2001NZ$4.3269.76%
2000NZ$2.55